Related Experiment Video
Updated: Jun 19, 2026
13:50
Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
[Portal hypertension and HIV infection]
L Spahr1, F Bihl, L Rubbia-Brandt
1Service de gastroentérologie et d'hépatologie, HUG, 1211 Geneve 14 Laurent. Laurent.Spahr@hcuge.ch
Revue Medicale Suisse
|October 7, 2009
Summary
Antiretroviral therapy improves survival in HIV patients, but chronic liver disease, including nodular regenerative hyperplasia, is a growing concern. This condition presents with portal hypertension and requires specific diagnostic and management strategies.
Area of Science:
- Hepatology
- Infectious Diseases
- Pathology
Context:
- Antiretroviral therapies have prolonged survival for patients with chronic HIV infection.
- Chronic liver diseases are emerging as a significant cause of mortality in HIV-infected individuals.
- Unexplained liver disease with portal hypertension is increasingly observed in this population.
Purpose:
- To describe the clinical presentation of nodular regenerative hyperplasia in HIV-infected patients.
- To elucidate the diagnostic aspects and pathogenic mechanisms of this emergent liver disease.
- To outline the management strategies for nodular regenerative hyperplasia in HIV-infected individuals.
Summary:
- Nodular regenerative hyperplasia (NRH) is a non-cirrhotic liver disease characterized by nodularity without significant fibrosis, stemming from portal vein obliteration.
- It is a frequent finding in HIV patients with unexplained liver disease and portal hypertension.
- This condition necessitates a comprehensive understanding of its clinical, diagnostic, and pathogenic features for effective management.
Impact:
- Highlights an emergent non-cirrhotic liver disease in the context of improved HIV survival.
- Emphasizes the need for recognizing and managing nodular regenerative hyperplasia in HIV-infected patients.
- Contributes to understanding the evolving landscape of chronic liver disease in the era of modern HIV treatment.
Related Concept Videos
01:22Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...